Figure 3From: Antidiabetic activity of isoquercetin in diabetic KK -Ay miceImmunohistochemical evaluation on pancreas (400 ×): (A) Diabetic KK-Ay mice showing the decrease of insulin immunoreactivity, (B) Diabetic KK-Ay mice orally given isoquercetin (200 mg/kg) showing an improvement in insulin immunoreactivity.Back to article page